Skip to main content
. 2018 Nov 15;13:7441–7455. doi: 10.2147/IJN.S170274

Figure 3.

Figure 3

Biodistribution of PLDs at different time points after a single IV injection of 10 mg/kg (AD) or 15 mg/kg (EI) liposomal DXR in different organs including serum (A, E), spleen and liver (B, F, and G), lungs and kidneys (C, H), and tumor (D, I) in BALB/c mice bearing C26 tumor. Data represent mean ± SE (n=4).

Abbreviations: TAT, transactivator of transcription; PLD, PEGylated liposomal doxorubicin; DXR, doxorubicin.